| Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities. |
|
| Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma |
|
| Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma. |
|
| Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma. |
|
| RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells |
|
| Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens |
|
| Parkin Somatic Mutations Link Melanoma and Parkinson's Disease |
|
| Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma |
|
| Recurrent inactivating RASA2 mutations in melanoma |
|
| Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma |
|
| The functional relevance of somatic synonymous mutations in melanoma and other cancer |
|
| A highly recurrent RPS27 5’UTR mutation in melanoma. |
|
| Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation |
|
| Signatures of historical demography and pathogen richness on MHC class I genes |
|
